Free Trial
→ Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th... (From Banyan Hill Publishing) (Ad)tc pixel Free AMPX Stock Alerts

Amprius Technologies (AMPX) Financials

Amprius Technologies logo
$17.83 +1.80 (+11.23%)
As of 03:58 PM Eastern
Compare
Annual Income Statements for Amprius Technologies

Annual Income Statements for Amprius Technologies

This table shows Amprius Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -9.90 -17 -37 -45 -44
Consolidated Net Income / (Loss)		 -9.90 -17 -37 -45 -44
Net Income / (Loss) Continuing Operations		 -9.90 -17 -37 -45 -44
Total Pre-Tax Income 		-9.90 -17 -37 -45 -44
Total Operating Income		 -11 -18 -39 -46 -47
Total Gross Profit		 -4.33 -5.65 -15 -18 8.26
Total Revenue		 2.77 4.41 9.05 24 73
Operating Revenue		 2.77 4.41 9.05 24 73
Total Cost of Revenue		 7.10 10 24 42 65
Operating Cost of Revenue		 7.10 10 24 42 65
Total Operating Expenses		 6.29 12 24 28 55
Selling, General & Admin Expense		 4.84 10 20 19 23
Research & Development Expense		 1.45 2.03 3.68 7.34 9.43
Restructuring Charge		 - - - 1.86 23
Total Other Income / (Expense), net		 0.73 0.71 1.93 1.59 2.62
Interest & Investment Income		 -0.02 0.71 2.51 1.59 2.62
Basic Earnings per Share		 ($0.15) ($0.24) ($0.43) ($0.45) ($0.35)
Weighted Average Basic Shares Outstanding		 65.76M 71.34M 86.20M 101.87M 124.64M
Diluted Earnings per Share		 ($0.15) ($0.24) ($0.43) ($0.45) ($0.35)
Weighted Average Diluted Shares Outstanding		 65.76M 71.34M 86.20M 101.87M 124.64M
Weighted Average Basic & Diluted Shares Outstanding		 - 84.63M 91.60M 117.93M 137.02M

Quarterly Income Statements for Amprius Technologies

This table shows Amprius Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -8.49 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24 -5.05
Consolidated Net Income / (Loss)		 -8.49 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24 -5.05
Net Income / (Loss) Continuing Operations		 -8.49 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24 -5.05
Total Pre-Tax Income 		-8.49 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24 -5.05
Total Operating Income		 -9.13 -9.74 -10 -13 -11 -12 -9.67 -6.81 -4.69 -25 -6.69
Total Gross Profit		 -4.25 -3.88 -4.45 -6.53 -5.10 -2.25 -2.36 1.34 3.32 5.97 5.74
Total Revenue		 2.80 3.94 2.34 3.35 7.86 11 11 15 21 25 29
Operating Revenue		 2.80 3.94 2.34 3.35 7.86 11 11 15 21 25 29
Total Cost of Revenue		 7.05 7.82 6.78 9.88 13 13 14 14 18 19 23
Operating Cost of Revenue		 7.05 7.82 6.78 9.88 13 13 14 14 18 19 23
Total Operating Expenses		 4.88 5.87 5.87 6.40 6.15 9.51 7.31 8.15 8.01 31 12
Selling, General & Admin Expense		 4.07 4.58 4.29 4.74 4.34 5.36 5.31 5.99 5.50 6.16 8.63
Research & Development Expense		 0.82 1.29 1.58 1.66 1.82 2.28 2.00 2.16 2.51 2.76 3.80
Total Other Income / (Expense), net		 0.64 0.01 0.43 0.42 0.40 0.34 0.30 0.44 0.80 1.08 1.64
Basic Earnings per Share		 ($0.10) ($0.11) ($0.11) ($0.13) ($0.10) ($0.11) ($0.08) ($0.05) ($0.03) ($0.19) ($0.04)
Weighted Average Basic Shares Outstanding		 86.35M 86.20M 90.03M 97.05M 110.41M 101.87M 117.97M 121.78M 126.63M 124.64M 136.95M
Diluted Earnings per Share		 ($0.10) ($0.11) ($0.11) ($0.13) ($0.10) ($0.11) ($0.08) ($0.05) ($0.03) ($0.19) ($0.04)
Weighted Average Diluted Shares Outstanding		 86.35M 86.20M 90.03M 97.05M 110.41M 101.87M 117.97M 121.78M 126.63M 124.64M 136.95M
Weighted Average Basic & Diluted Shares Outstanding		 88.40M 91.60M 94.47M 111.05M 105.84M 117.93M 120.55M 125.08M 130.48M 137.02M 141.63M

Annual Cash Flow Statements for Amprius Technologies

This table details how cash moves in and out of Amprius Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 11 58 -24 11 36
Net Cash From Operating Activities		 -8.02 -14 -26 -33 -31
Net Cash From Continuing Operating Activities		 -8.02 -14 -26 -33 -31
Net Income / (Loss) Continuing Operations		 -9.90 -17 -37 -45 -44
Consolidated Net Income / (Loss)		 -9.90 -17 -37 -45 -44
Depreciation Expense		 1.44 1.54 1.81 3.81 4.37
Amortization Expense		 0.55 1.59 3.06 6.39 5.14
Non-Cash Adjustments To Reconcile Net Income		 1.89 3.27 5.61 9.21 30
Changes in Operating Assets and Liabilities, net		 -2.00 -2.94 0.75 -8.08 -27
Net Cash From Investing Activities		 -0.61 -1.48 -18 -3.21 -4.40
Net Cash From Continuing Investing Activities		 -0.61 -1.48 -18 -3.21 -4.40
Purchase of Property, Plant & Equipment		 -0.61 -1.48 -18 -3.21 -4.40
Net Cash From Financing Activities		 20 74 19 47 71
Net Cash From Continuing Financing Activities		 20 74 19 47 71
Repurchase of Common Equity		 0.00 -0.33 -0.60 -0.76 0.00
Issuance of Common Equity		 0.00 78 19 33 64
Other Financing Activities, net		 20 -3.93 0.31 14 7.37
Effect of Exchange Rate Changes		 - - - 0.00 0.00

Quarterly Cash Flow Statements for Amprius Technologies

This table details how cash moves in and out of Amprius Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -12 -7.64 -5.52 7.40 -11 20 -6.53 5.78 19 17 -29
Net Cash From Operating Activities		 -8.68 -4.80 -9.78 -7.96 -9.53 -6.09 -14 -4.27 -9.25 -3.50 -37
Net Cash From Continuing Operating Activities		 -8.68 -4.80 -9.78 -7.96 -9.53 -6.09 -14 -4.27 -9.25 -3.50 -37
Net Income / (Loss) Continuing Operations		 -8.49 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24 -5.05
Consolidated Net Income / (Loss)		 -8.49 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24 -5.05
Depreciation Expense		 0.46 0.49 1.02 1.04 0.86 0.89 0.94 1.02 1.18 1.22 0.76
Amortization Expense		 1.48 1.18 1.29 - 5.10 1.29 1.29 1.29 1.29 1.29 0.62
Non-Cash Adjustments To Reconcile Net Income		 0.61 2.84 1.25 3.23 -0.85 4.30 2.10 2.45 1.39 24 1.76
Changes in Operating Assets and Liabilities, net		 -2.74 0.43 -3.44 0.30 -3.80 -1.14 -9.08 -2.65 -9.21 -6.07 -36
Net Cash From Investing Activities		 -8.93 -5.75 -3.90 -1.61 -1.33 3.63 -0.91 -0.72 -0.41 -2.36 -0.63
Net Cash From Continuing Investing Activities		 -8.93 -5.75 -3.90 -1.61 -1.33 3.63 -0.91 -0.72 -0.41 -2.36 -0.63
Purchase of Property, Plant & Equipment		 -8.93 -5.75 -3.90 -1.61 -1.33 3.63 -0.91 -0.72 -0.41 -2.36 -0.98
Sale of Property, Plant & Equipment		 - - - - - - 0.00 - - - 0.36
Net Cash From Financing Activities		 6.00 2.92 8.16 17 -0.54 23 8.51 11 29 23 8.58
Net Cash From Continuing Financing Activities		 6.00 2.92 8.16 17 -0.54 23 8.51 11 29 23 8.58
Issuance of Common Equity		 6.04 2.92 8.13 2.73 - 23 8.46 9.74 26 20 0.00
Other Financing Activities, net		 0.11 0.20 0.03 14 - 0.01 0.05 1.02 2.83 3.47 8.58
Effect of Exchange Rate Changes		 - - 0.00 - - - -0.00 -0.00 0.00 0.01 0.01

Annual Balance Sheets for Amprius Technologies

This table presents Amprius Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 19 83 108 121 157
Total Current Assets		 14 75 51 69 126
Cash & Equivalents		 11 70 46 55 90
Accounts Receivable		 0.26 0.69 1.27 5.58 24
Inventories, net		 0.50 0.50 0.73 6.57 6.74
Prepaid Expenses		 0.16 2.39 1.99 1.45 5.50
Plant, Property, & Equipment, net		 4.21 4.24 22 17 9.68
Total Noncurrent Assets		 0.14 3.76 35 35 21
Other Noncurrent Operating Assets		 0.14 3.76 35 35 21
Total Liabilities & Shareholders' Equity		 19 83 108 121 157
Total Liabilities		 4.67 10 48 52 53
Total Current Liabilities		 4.17 6.92 13 17 18
Accounts Payable		 1.81 3.74 8.94 12 10
Current Deferred Revenue		 2.36 2.66 3.43 1.64 2.84
Other Current Liabilities		 0.00 0.52 1.09 3.32 4.67
Total Noncurrent Liabilities		 0.50 3.22 34 34 35
Other Noncurrent Operating Liabilities		 0.00 2.50 34 34 35
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 14 73 60 69 104
Total Preferred & Common Equity		 14 73 60 69 104
Preferred Stock		 - 0.00 0.00 0.00 0.00
Total Common Equity		 14 73 60 69 104
Common Stock		 89 166 189 244 322
Retained Earnings		 -75 -93 -130 -174 -218
Accumulated Other Comprehensive Income / (Loss)		 - - - 0.00 0.00

Quarterly Balance Sheets for Amprius Technologies

This table presents Amprius Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 87 84 87 87 105 113 104 118 123 156 131
Total Current Assets		 78 70 71 61 46 53 45 66 72 107 114
Cash & Equivalents		 74 64 65 53 39 46 35 48 54 73 62
Accounts Receivable		 0.78 0.56 1.13 1.89 1.44 1.74 4.59 10 11 22 35
Inventories, net		 0.50 0.85 0.50 0.49 0.86 1.53 2.66 4.00 4.34 4.68 8.25
Prepaid Expenses		 2.32 1.84 1.48 2.74 3.35 2.17 2.64 3.31 2.56 6.88 8.10
Plant, Property, & Equipment, net		 3.82 4.95 6.90 17 23 24 24 18 17 16 11
Total Noncurrent Assets		 4.86 9.10 9.03 8.55 36 36 35 34 34 33 6.08
Other Noncurrent Operating Assets		 4.86 9.10 9.03 8.55 36 36 35 34 34 33 6.08
Total Liabilities & Shareholders' Equity		 87 84 87 87 105 113 104 118 123 156 131
Total Liabilities		 11 17 20 21 45 48 48 48 46 53 21
Total Current Liabilities		 6.14 8.88 12 14 9.76 13 13 14 12 16 16
Accounts Payable		 4.82 4.69 7.74 9.23 5.42 7.76 9.13 8.55 7.81 12 12
Current Deferred Revenue		 0.80 3.14 3.20 3.57 3.24 3.15 1.82 1.78 0.84 0.71 2.76
Other Current Liabilities		 0.52 1.06 1.07 1.08 1.10 1.92 2.05 3.64 3.43 3.22 1.17
Total Noncurrent Liabilities		 4.36 8.03 7.94 6.98 35 35 35 34 34 37 5.39
Other Noncurrent Operating Liabilities		 2.58 7.13 7.00 6.87 35 35 35 34 34 37 5.39
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 76 67 67 66 60 65 56 70 77 103 109
Total Preferred & Common Equity		 76 67 67 66 60 65 56 70 77 103 109
Preferred Stock		 - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 76 67 67 66 60 65 56 70 77 103 109
Common Stock		 163 169 178 186 199 217 219 254 267 297 333
Retained Earnings		 -87 -102 -111 -120 -140 -152 -163 -184 -190 -194 -223
Accumulated Other Comprehensive Income / (Loss)		 - - - - - - - -0.00 -0.01 -0.00 0.01

Annual Metrics And Ratios for Amprius Technologies

This table displays calculated financial ratios and metrics derived from Amprius Technologies' official financial filings.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 - - - - 130,483,838.00
DEI Adjusted Shares Outstanding		 - - - - 130,483,838.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - -0.34
Growth Metrics		 - - - - -
Profitability Metrics		 - - - - -
Net Operating Profit after Tax (NOPAT)		 -7.44 -13 -27 -32 -33
Return On Investment Capital (ROIC_SIMPLE)		 - - -45.31% -46.61% -31.45%
Earnings before Interest and Taxes (EBIT)		 -11 -18 -39 -46 -47
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -8.63 -15 -34 -36 -37
Valuation Ratios		 - - - - -
Leverage & Solvency		 - - - - -
Liquidity Ratios		 - - - - -
Cash Flow Metrics		 - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -14 -38 -33 -32
Efficiency Ratios		 - - - - -
Capital & Investment Metrics		 - - - - -
Invested Capital		 2.37 3.34 14 14 13
Increase / (Decrease) in Invested Capital		 0.00 0.97 11 0.28 -0.97
Book Value per Share		 $0.21 $0.86 $0.68 $0.66 $0.80
Tangible Book Value per Share		 $0.21 $0.86 $0.68 $0.66 $0.80
Total Capital		 14 73 60 69 104
Total Debt		 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00
Net Debt		 -11 -70 -46 -55 -90
Capital Expenditures (CapEx)		 0.61 1.48 18 3.21 4.40
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -1.48 -1.44 -8.70 -3.60 18
Debt-free Net Working Capital (DFNWC)		 10 68 37 52 109
Net Working Capital (NWC)		 10 68 37 52 109
Net Nonoperating Expense (NNE)		 2.46 4.70 9.68 12 11
Net Nonoperating Obligations (NNO)		 -11 -70 -46 -55 -90
Total Depreciation and Amortization (D&A)		 1.99 3.12 4.86 10 9.51
Earnings Adjustments		 - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($0.24) ($0.43) ($0.45) ($0.35)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 71.34M 86.20M 101.87M 124.64M
Adjusted Diluted Earnings per Share		 $0.00 ($0.24) ($0.43) ($0.45) ($0.35)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 71.34M 86.20M 101.87M 124.64M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 84.63M 91.60M 117.93M 137.02M
Normalized Net Operating Profit after Tax (NOPAT)		 -7.44 -13 -27 -31 -17
Debt Service Ratios		 - - - - -
Payout Ratios		 - - - - -

Quarterly Metrics And Ratios for Amprius Technologies

This table displays calculated financial ratios and metrics derived from Amprius Technologies' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - 130,483,838.00 137,019,004.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 130,483,838.00 137,019,004.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - -0.19 -0.04
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 242.89% 397.98% 244.04% 104.96% 180.74% 169.55% 383.05% 350.43% 172.77% - 152.89%
EBITDA Growth		 -99.83% -29.32% -3.37% -24.21% 26.48% -18.58% 7.16% 57.50% 81.01% - 28.69%
EBIT Growth		 -111.22% -46.59% -5.83% -28.26% -23.24% -20.67% 6.28% 47.32% 58.30% - 30.86%
NOPAT Growth		 -111.22% -46.59% -5.83% -28.26% -23.24% -20.67% 6.28% 47.32% 58.30% - 30.86%
Net Income Growth		 -100.09% -60.73% -8.61% -32.48% -27.77% -17.30% 5.21% 49.11% 64.13% - 46.15%
EPS Growth		 -66.67% -37.50% 0.00% -18.18% 0.00% 0.00% 27.27% 61.54% 70.00% - 50.00%
Operating Cash Flow Growth		 -222.36% 15.76% -50.63% -42.56% -9.81% -26.77% -44.45% 46.41% 2.97% - -163.88%
Free Cash Flow Firm Growth		 -216.79% 0.00% -112.85% -112.94% 0.49% 51.44% 68.90% 67.18% 25.33% - -278.74%
Invested Capital Growth		 462.07% 320.71% 633.50% 1,012.02% 69.53% 1.98% 5.21% 20.25% 43.02% - 114.12%
Revenue Q/Q Growth		 71.45% 40.96% -40.77% 43.19% 134.83% 35.34% 6.14% 33.53% 42.20% - 13.09%
EBITDA Q/Q Growth		 24.92% -12.38% -27.97% -27.89% 55.56% -81.25% 22.33% 39.40% 50.67% - 76.89%
EBIT Q/Q Growth		 9.44% -6.71% -5.90% -25.32% 12.98% -4.49% 17.75% 29.55% 31.13% - 73.75%
NOPAT Q/Q Growth		 9.44% -6.71% -5.90% -25.32% 12.98% -4.49% 17.75% 29.55% 31.13% - 73.75%
Net Income Q/Q Growth		 10.12% -14.63% -1.56% -26.61% 13.32% -5.24% 17.93% 32.02% 38.90% - 79.31%
EPS Q/Q Growth		 9.09% -10.00% 0.00% -18.18% 23.08% -10.00% 27.27% 37.50% 40.00% - 78.95%
Operating Cash Flow Q/Q Growth		 -55.44% 44.69% -103.73% 18.61% -19.73% 36.14% -132.14% 69.81% -116.79% - -965.91%
Free Cash Flow Firm Q/Q Growth		 -108.22% -5.86% -44.19% -3.12% 36.78% 48.34% 7.64% -8.82% -43.81% - -76.51%
Invested Capital Q/Q Growth		 635.71% 13.58% 48.80% -10.57% 12.16% -31.67% 53.52% 2.21% 33.40% - 252.52%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 -151.82% -98.35% -190.28% -195.25% -64.94% -21.19% -20.92% 8.89% 15.49% - 20.11%
EBITDA Margin		 -256.97% -204.87% -398.20% -355.64% -67.29% -90.12% -65.95% -29.93% -10.38% - -18.60%
Operating Margin		 -326.34% -247.06% -441.74% -386.61% -143.26% -110.60% -85.71% -45.22% -21.90% - -23.43%
EBIT Margin		 -326.34% -247.06% -441.74% -386.61% -143.26% -110.60% -85.71% -45.22% -21.90% - -23.43%
Profit (Net Income) Margin		 -303.50% -246.81% -423.20% -374.20% -138.13% -107.40% -83.05% -42.28% -18.16% - -17.68%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% - 100.00%
Interest Burden Percent		 93.00% 99.90% 95.80% 96.79% 96.42% 97.11% 96.90% 93.50% 82.95% - 75.46%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Return on Invested Capital (ROIC)		 -185.18% -180.21% -279.02% -330.22% -105.24% -131.97% -92.69% -68.98% -35.17% - -42.89%
ROIC Less NNEP Spread (ROIC-NNEP)		 -181.88% -175.16% -273.86% -324.00% -98.51% -125.65% -86.74% -65.80% -34.04% - -42.23%
Return on Net Nonoperating Assets (RNNOA)		 163.20% 152.25% 222.66% 273.95% 71.56% 98.09% 58.21% 46.70% 23.15% - 26.02%
Return on Equity (ROE)		 -21.98% -27.96% -56.36% -56.27% -33.68% -33.88% -34.48% -22.28% -12.01% - -16.87%
Cash Return on Invested Capital (CROIC)		 0.00% -435.06% -383.65% -456.64% -237.54% -230.37% -154.05% -152.77% -125.95% - -161.20%
Operating Return on Assets (OROA)		 -22.25% -23.43% -50.16% -48.17% -26.25% -23.36% -25.44% -17.20% -9.81% - -16.97%
Return on Assets (ROA)		 -20.69% -23.41% -48.06% -46.63% -25.31% -22.68% -24.65% -16.08% -8.14% - -12.81%
Return on Common Equity (ROCE)		 -21.98% -27.96% -56.36% -56.27% -33.68% -33.88% -34.48% -22.28% -12.01% - -16.87%
Return on Equity Simple (ROE_SIMPLE)		 -50.33% 0.00% -62.67% -62.38% -76.76% 0.00% -62.73% 0.00% 0.00% - 0.00%
Net Operating Profit after Tax (NOPAT)		 -6.39 -6.82 -7.22 -9.05 -7.88 -8.23 -6.77 -4.77 -3.28 -18 -4.68
NOPAT Margin		 -228.44% -172.94% -309.22% -270.62% -100.28% -77.42% -59.99% -31.65% -15.33% - -16.40%
Net Nonoperating Expense Percent (NNEP)		 -3.30% -5.05% -5.16% -6.22% -6.72% -6.32% -5.95% -3.18% -1.12% - -0.66%
Return On Investment Capital (ROIC_SIMPLE)		 - -11.41% - - - -11.85% -9.62% -6.22% -3.18% -17.17% -4.28%
Cost of Revenue to Revenue		 251.82% 198.35% 290.28% 295.25% 164.94% 121.19% 120.92% 91.11% 84.51% - 79.89%
SG&A Expenses to Revenue		 145.39% 116.00% 183.78% 141.67% 55.19% 50.41% 47.03% 39.76% 25.67% - 30.24%
R&D to Revenue		 29.13% 32.71% 67.68% 49.69% 23.13% 21.48% 17.75% 14.35% 11.71% - 13.31%
Operating Expenses to Revenue		 174.52% 148.71% 251.46% 191.36% 78.32% 89.41% 64.78% 54.11% 37.38% - 43.55%
Earnings before Interest and Taxes (EBIT)		 -9.13 -9.74 -10 -13 -11 -12 -9.67 -6.81 -4.69 -25 -6.69
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -7.19 -8.08 -9.30 -12 -5.29 -9.58 -7.44 -4.51 -2.23 -23 -5.31
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 6.22 7.82 4.05 1.84 2.20 4.27 4.49 6.62 12.75 - 21.11
Price to Tangible Book Value (P/TBV)		 6.22 7.82 4.05 1.84 2.20 4.27 4.49 6.62 12.75 - 21.11
Price to Revenue (P/Rev)		 69.30 51.65 22.66 9.66 7.05 12.26 9.54 11.32 22.53 - 25.59
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Enterprise Value to Invested Capital (EV/IC)		 28.77 30.05 9.75 3.94 4.21 16.85 12.18 20.18 41.46 - 47.76
Enterprise Value to Revenue (EV/Rev)		 60.25 46.60 19.02 5.92 5.05 9.98 8.08 10.11 21.27 - 24.90
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Financial Leverage		 -0.90 -0.87 -0.81 -0.85 -0.73 -0.78 -0.67 -0.71 -0.68 - -0.62
Leverage Ratio		 1.22 1.44 1.49 1.51 1.57 1.77 1.71 1.66 1.64 - 1.39
Compound Leverage Factor		 1.14 1.44 1.42 1.46 1.51 1.72 1.66 1.56 1.36 - 1.05
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% - 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Altman Z-Score		 10.20 4.37 1.58 -0.22 -0.48 1.82 2.31 5.17 14.05 - 63.89
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 4.42 3.75 4.67 4.14 3.46 4.00 4.74 5.95 6.65 - 7.13
Quick Ratio		 3.98 3.49 4.15 3.76 3.05 3.53 4.21 5.38 5.93 - 6.11
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -17 -18 -25 -26 -16 -8.51 -7.86 -8.55 -12 -17 -30
Operating Cash Flow to CapEx		 -97.17% -83.46% -251.00% -495.89% -714.85% 0.00% -1,547.21% -595.67% -2,233.33% - -5,964.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.07 0.09 0.11 0.12 0.18 0.21 0.30 0.38 0.45 - 0.72
Accounts Receivable Turnover		 4.42 9.28 10.73 8.66 5.40 7.06 5.59 7.17 4.41 - 3.95
Inventory Turnover		 37.25 38.58 30.90 31.06 23.76 11.64 20.31 18.15 15.90 - 12.07
Fixed Asset Turnover		 0.58 0.70 0.77 0.81 0.86 1.23 1.62 2.18 2.90 - 6.29
Accounts Payable Turnover		 2.62 3.75 5.21 4.07 4.08 4.01 7.07 6.83 5.49 - 7.18
Days Sales Outstanding (DSO)		 82.54 39.33 34.03 42.13 67.62 51.69 65.24 50.90 82.82 - 92.31
Days Inventory Outstanding (DIO)		 9.80 9.46 11.81 11.75 15.36 31.37 17.97 20.10 22.96 - 30.25
Days Payable Outstanding (DPO)		 139.07 97.45 70.12 89.71 89.49 91.00 51.65 53.41 66.49 - 50.87
Cash Conversion Cycle (CCC)		 -46.73 -48.66 -24.28 -35.83 -6.51 -7.95 31.57 17.59 39.29 - 71.69
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 12 14 21 19 21 14 22 22 30 13 47
Invested Capital Turnover		 0.81 1.04 0.90 1.22 1.05 1.70 1.54 2.18 2.29 - 2.61
Increase / (Decrease) in Invested Capital		 10 11 18 17 8.59 0.28 1.09 3.78 9.01 -0.97 25
Enterprise Value (EV)		 356 422 204 74 88 241 268 453 1,243 - 2,248
Market Capitalization		 409 468 243 120 123 296 316 507 1,316 - 2,310
Book Value per Share		 $0.76 $0.68 $0.65 $0.69 $0.50 $0.66 $0.60 $0.64 $0.83 $0.80 $0.80
Tangible Book Value per Share		 $0.76 $0.68 $0.65 $0.69 $0.50 $0.66 $0.60 $0.64 $0.83 $0.80 $0.80
Total Capital		 66 60 60 65 56 69 70 77 103 104 109
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -53 -46 -39 -46 -35 -55 -48 -54 -73 -90 -62
Capital Expenditures (CapEx)		 8.93 5.75 3.90 1.61 1.33 -3.63 0.91 0.72 0.41 2.36 0.63
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -5.88 -8.70 -3.18 -6.23 -3.11 -3.60 3.75 5.59 17 18 36
Debt-free Net Working Capital (DFNWC)		 48 37 36 40 32 52 52 60 91 109 98
Net Working Capital (NWC)		 48 37 36 40 32 52 52 60 91 109 98
Net Nonoperating Expense (NNE)		 2.10 2.91 2.66 3.46 2.97 3.19 2.60 1.60 0.61 6.56 0.37
Net Nonoperating Obligations (NNO)		 -53 -46 -39 -46 -35 -55 -48 -54 -73 -90 -62
Total Depreciation and Amortization (D&A)		 1.94 1.66 1.02 1.04 5.97 2.18 2.23 2.30 2.47 2.51 1.38
Debt-free, Cash-free Net Working Capital to Revenue		 -99.59% -96.06% -29.73% -50.15% -17.76% -14.90% 11.31% 12.46% 29.84% - 39.46%
Debt-free Net Working Capital to Revenue		 805.27% 409.42% 334.84% 323.73% 182.72% 213.32% 157.52% 133.32% 155.20% - 108.54%
Net Working Capital to Revenue		 805.27% 409.42% 334.84% 323.73% 182.72% 213.32% 157.52% 133.32% 155.20% - 108.54%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.10) ($0.11) ($0.11) ($0.13) ($0.10) ($0.11) ($0.08) ($0.05) ($0.03) ($0.19) ($0.04)
Adjusted Weighted Average Basic Shares Outstanding		 86.35M 86.20M 90.03M 97.05M 110.41M 101.87M 117.97M 121.78M 126.63M 124.64M 136.95M
Adjusted Diluted Earnings per Share		 ($0.10) ($0.11) ($0.11) ($0.13) ($0.10) ($0.11) ($0.08) ($0.05) ($0.03) ($0.19) ($0.04)
Adjusted Weighted Average Diluted Shares Outstanding		 86.35M 86.20M 90.03M 97.05M 110.41M 101.87M 117.97M 121.78M 126.63M 124.64M 136.95M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 88.40M 91.60M 94.47M 111.05M 105.84M 117.93M 120.55M 125.08M 130.48M 137.02M 141.63M
Normalized Net Operating Profit after Tax (NOPAT)		 -6.39 -6.82 -7.22 -9.05 -7.88 -8.23 -6.77 -4.77 -3.28 -18 -4.68
Normalized NOPAT Margin		 -228.44% -172.94% -309.22% -270.62% -100.28% -77.42% -59.99% -31.65% -15.33% - -16.40%
Pre Tax Income Margin		 -303.50% -246.81% -423.20% -374.20% -138.13% -107.40% -83.05% -42.28% -18.16% - -17.68%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Augmented Payout Ratio		 -2.14% -1.63% -0.89% -1.39% -2.21% -1.69% 0.00% -1.42% 0.00% - 0.00%

Financials Breakdown Chart

Key Financial Trends

Amprius Technologies (AMPX) shows a clear revenue recovery in 2025, a notable gross margin improvement in Q4, and improved liquidity driven by financing activity. However, the company remains unprofitable with ongoing cash burn from operations and a large accumulated deficit. Here are the 10 most important takeaways from the last four years of quarterly statements:

  • Revenue growth: total revenue rose through 2025, from about 11.28 million in Q1 2025 to about 25.23 million in Q4 2025 (Q2 2025: 15.07M; Q3 2025: 21.43M).
  • Gross margin improvement: Q4 2025 gross margin reached about 23.7% (5.97M gross profit on 25.23M revenue), a meaningful improvement from earlier 2025 quarters (Q3 2025 ~15.5%, Q2 2025 ~8.9%).
  • Liquidity growth: cash and equivalents rose to about 73.2 million by Q3 2025, up from roughly 54.2 million in Q2 2025 and 48.4 million in Q1 2025, signaling better near‑term liquidity.
  • Financing support: net cash from financing activities was strong in 2025 (Q3 2025 around +28.7M; Q4 2025 around +23.1M), helped by equity issuance (Q4 2025 issuance of common equity about 19.6M).
  • Capital cushion: Total Common Equity was around 103.2 million in Q3 2025, indicating a solid capitalization base to support ongoing operations.
  • Profits still elusive: 2025 remains unprofitable, with net income of about -3.89 million in Q3 2025 and -24.39 million in Q4 2025 (quarterly net losses vary by period).
  • Cash burn from operations: negative net cash from operating activities in every 2025 quarter (Q4 2025 around -3.50M; Q3 2025 around -9.25M; Q2 2025 around -4.27M; Q1 2025 around -14.13M).
  • Elevated expense base: SG&A and R&D remain high relative to revenue (Q4 2025 SG&A about 6.16M; R&D about 2.76M on 25.23M of revenue), continuing to pressure margins.
  • Retained earnings deficit: negative retained earnings around -193.97 million by Q3 2025, underscoring decades of losses and a long path to profitability.
  • Dilution risk: substantial equity issuances in 2025 increased shares outstanding and may dilute existing shareholders, despite the near‑term liquidity benefits.
05/26/26 05:02 PM ETAI Generated. May Contain Errors.

Amprius Technologies Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Amprius Technologies' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Amprius Technologies' net income appears to be on an upward trend, with a most recent value of -$44.02 million in 2025, rising from -$9.90 million in 2021. The previous period was -$44.67 million in 2024. View Amprius Technologies' forecast to see where analysts expect Amprius Technologies to go next.

Amprius Technologies' total operating income in 2025 was -$46.65 million, based on the following breakdown:
  • Total Gross Profit: $8.26 million
  • Total Operating Expenses: $54.91 million

Over the last 4 years, Amprius Technologies' total revenue changed from $2.77 million in 2021 to $73.01 million in 2025, a change of 2,533.9%.

Amprius Technologies' total liabilities were at $53.08 million at the end of 2025, a 2.8% increase from 2024, and a 1,036.8% increase since 2021.

In the past 4 years, Amprius Technologies' cash and equivalents has ranged from $11.49 million in 2021 to $90.47 million in 2025, and is currently $90.47 million as of their latest financial filing in 2025.

Over the last 4 years, Amprius Technologies' book value per share changed from 0.21 in 2021 to 0.80 in 2025, a change of 277.6%.


Related Companies

Financial statements for NYSE:AMPX last updated on 5/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
Elon Confirms SpaceX IPO For 6/12 [Act Now!]
Elon Musk has confirmed SpaceX will IPO on Friday, June 12, 2026, at a valuation of up to $2 trillion - potent...
Paradigm Press | Sponsoredtc pixel
I was right about SpaceX. Now here's the part that matters
Goldman Sachs and JP Morgan have already been tied to allocations surrounding the SpaceX deal. When the bigges...
The Oxford Club | Sponsoredtc pixel
June 4: The day smart money moves (not June 12)
Everyone is watching June 12 - the SpaceX listing date. The real deadline is June 4, when Goldman Sachs, Morga...
Behind the Markets | Sponsoredtc pixel
Your $29.97 book is free today
Bill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...
Profits Run | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel